Peer Review Publications:
Sean P. Kennedy, Michael O’Neill, Darren Cunningham, Oncogene(2020), 10 February 2020.
"Co-targeting PIM kinase to overcome MET amplified resistance to EGFR TKIs in NSCLC"
2019 IASLC World Conference on Lung Cancer, Barcelona, September 7-10, 2019.
"Activation of the MACC1/PIM/cMyc axis confers resistance to PI3K/mTOR inhibition in PIK3CA mutant NSCLC"
2018 AACR Targeting PI3K/mTOR Signaling Conference, November 30-December 3, 2018, Boston MA.
2018 American Association for Cancer Research (AACR) Annual Meeting, April 14-18, 2018 in Chicago.
"Initial Evaluation of Novel Dual PIM/PI3K and Triple PIM/PI3K/MTOR inhibitors in multiple myeloma"
20th Congress of the European Hematology Association (EHA) June 11 – 14, 2015, Vienna.
American Association for Cancer Research (AACR) Annual Meeting 2014, April 5-9, San Diego, California.
2013 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference, Boston, USA.